Log in
Forgot password ?
Become a member for free
Sign up
Sign up
Dynamic quotes 

MarketScreener Homepage  >  Equities  >  Nyse  >  Procter & Gamble Company    PG

My previous session
Most popular
Analysis summaryMarketScreener Strategies

Top of the trading range

share with twitter share with LinkedIn share with facebook
share via e-mail
08/21/2014 | 03:34pm

The stock is close to a strong resistance level and poor fundamentals suggest a price correction in coming sessions.

From a fundamental viewpoint, the company's activities offer little revenue growh perpesctives and analysts have revised downward their sales and EPS estimates. The group seems overvalued as suggested by its P/E ratio at 18.8 for current year estimates and an EV/EBITDA ratio at 12.7.

Graphically, the share is in a period of technical rebound that allowed it to reach the USD 82.95 mid-term resistance. This area could trigger a sell signal for investors in case of profit-taking. In fact, it represents the top of the trading range with encompass prices since early 2014. Thus, the downward movement could bring the stock back to USD 77.30 during the upcoming sessions.

The upside seems limited as shown by fundamentals and technical configuration. In contact with the USD 82.95 resistance, a movement of consolidation could return the stock towards the USD 77.3 mid-term support. As a result, the most aggressive investors could take a short position near USD 82.9 but they need to set a stop loss above this resistance because the crossing of this level would invalidate our scenario.

Alexis Peyrard
© Zonebourse.com 2014
share with twitter share with LinkedIn share with facebook
share via e-mail

Disclaimer: The information, charts, data, views, or comments provided by SURPERFORMANCE SAS are intended for investors who have the necessary knowledge and experience to understand and appreciate the information contained within. These items are disseminated for personal reference only. They do not constitute an offer or solicitation to buy or sell financial products or services, nor an investment advice.
The use of the information disseminated takes place under the investor's sole responsibility, without recourse against SURPERFORMANCE SAS. SURPERFORMANCE SAS will not be liable, whether in contract, in tort, under any warranty, for errors, omissions, improper investments, or adverse evolution of markets.

Financials ($)
Sales 2019 66 955 M
EBIT 2019 14 669 M
Net income 2019 11 224 M
Debt 2019 30 479 M
Yield 2019 3,52%
P/E ratio 2019 19,02
P/E ratio 2020 17,76
EV / Sales 2019 3,55x
EV / Sales 2020 3,45x
Capitalization 207 B
Surperformance© ratings
Fundamental ratings
Overall rating
Trading Rating
Investor Rating
Growth (Revenue)
Earnings quality
Business Predictability
P/E ratio
7 days EPS revision
4 months EPS revision
1 year EPS revision
4 months Revenue revision
1 year Revenue revision
Technical ratings
Short Term Timing
Middle Term Timing
Long Term Timing
Bollinger Spread
Unusual Volumes
Duration : Period : Day
Procter & Gamble Company Technical Analysis Chart | MarketScreener
Duration : Period : Week
Procter & Gamble Company Technical Analysis Chart | MarketScreener